Aquestive Therapeutics, Inc.
Aquestive Therapeutics, Inc. (AQST) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · AQST · as of Jun 8, 2026
Key Statistics
Explore Aquestive Therapeutics, Inc. Data
aqst stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 10 · Buy rate: 100.0%
The AQST analyst consensus is Buy, based on ratings from 10 Wall Street analysts over the past 3 months. The average 12-month price target is $9.00, representing +129.01% upside from the current price of $3.93.
Competitors & Peers
aqst competitorsAQST
ARVN
AVXL
DRIO
EBS
ERASStock Performance
Full HistoryAbout Aquestive Therapeutics, Inc.
Aquestive Therapeutics, Inc. a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally…
what is aquestive therapeutics, inc. · aqst stock overview · aquestive therapeutics, inc. company profile · who is aquestive therapeutics, inc. ceo · aqst NASDAQ · aquestive therapeutics, inc. headquarters · aquestive therapeutics, inc. business segments
About Stock Overview & Key Data
Aquestive Therapeutics, Inc. (AQST) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry, listed on NASDAQ since Jul 25, 2018. As of the latest trading session, AQST stock price is $3.93, with a market capitalization of $390.3M. The stock has returned +11.02% over the past 12 months and -39.16% year-to-date.
According to 10 Wall Street analysts, the consensus rating for Aquestive Therapeutics, Inc. stock is Buy, with an average 12-month price target of $9.00. In fiscal year 2025, Aquestive Therapeutics, Inc. reported revenue of $44.5M and net income of -$83.8M. For detailed data — including Aquestive Therapeutics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Aquestive Therapeutics, Inc. (AQST) stock price is $3.93. The stock is traded on NASDAQ under the ticker symbol AQST. The 52-week range is $2.93 – $7.55.